1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Read More
59.60 1.49 (2.56%)
New 52W High in past week
1.5M
XNAS Volume

XNAS 04 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Protagonist Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
30.2 / 100
Momentum Score
Technically Bullish
71.7 / 100
Momentum Trap These stocks are with bad quality but mid-range Valuation. However, their good technical scoring may generate some interest amongst the audience. View Similar Embed DVM
Analyst Price Target
70
1Yr Price target upside is 17%
11 analysts

22

S

10

W

3

O

1

T

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..